當(dāng)前位置：首頁 JCRQ3 期刊介紹(非官網(wǎng))

Current Pharmaceutical BiotechnologySCIE

國際簡稱：CURR PHARM BIOTECHNO 參考譯名：當(dāng)前的制藥生物技術(shù)

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q3

基本信息：: ISSN：1389-2010; E-ISSN：1873-4316; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Bentham Science Publishers B.V.; 出版語言：English; 出版周期：Bimonthly; 出版年份：2000; 研究方向：醫(yī)學(xué)-生化與分子生物學(xué)

評價(jià)信息：: 影響因子：2.2; H-index：73; CiteScore指數(shù)：5.6; SJR指數(shù)：0.492; SNIP指數(shù)：0.547

發(fā)文數(shù)據(jù)：: Gold OA文章占比：0.66%; 研究類文章占比：38.13%; 年發(fā)文量：139; 自引率：0.0357...; 開源占比：0.0043; 出版撤稿占比：0; 出版國人文章占比：0.12; OA被引用占比：0

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Current Pharmaceutical Biotechnology期刊介紹

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include:

DNA/protein engineering and processing

Synthetic biotechnology

Omics (genomics, proteomics, metabolomics and systems biology)

Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes)

Drug delivery and targeting

Nanobiotechnology

Molecular pharmaceutics and molecular pharmacology

Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)

Pharmacokinetics and pharmacodynamics

Applied Microbiology

Bioinformatics (computational biopharmaceutics and modeling)

Environmental biotechnology

Regenerative medicine (stem cells, tissue engineering and biomaterials)

Translational immunology (cell therapies, antibody engineering, xenotransplantation)

Industrial bioprocesses for drug production and development

Biosafety

Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

期刊簡介Current Pharmaceutical Biotechnology期刊介紹

《Current Pharmaceutical Biotechnology》自2000出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：一般,3-6周
醫(yī)學(xué)
BIOCHEMISTRY & MOLECULAR BIOLOGY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Current Pharmaceutical Biotechnology Cite Score數(shù)據(jù)

CiteScore：5.6
SJR：0.492
SNIP：0.547

學(xué)科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmaceutical Science	Q2	62 / 183	66%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Biotechnology	Q2	128 / 311	59%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價(jià)。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Current Pharmaceutical Biotechnology 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Current Pharmaceutical Biotechnology JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q4	237 / 313	24.4%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q3	204 / 354	42.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q3	226 / 313	27.96%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q3	232 / 354	34.6%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
CHINA MAINLAND64
India60
Iran37
Italy37
Poland33
USA30
Saudi Arabia27
Egypt21
Greece18
Japan14

本刊中國學(xué)者近年發(fā)表論文

1、The Role of VEGF Family in Lipid Metabolism
Author: Zhou, Yan; Zhu, Xueping; Wang, Huan; Duan, Chenglin; Cui, Hanming; Shi, Jingjing; Shi, Shuai; Yuan, Guozhen; Hu, Yuanhui

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 253-265. DOI: 10.2174/1389201023666220506105026
2、Distribution of Nicotinamide Mononucleotide after Intravenous Injection in Normal and Ischemic Stroke Mice
Author: Zheng, Si-Li; Wang, Dong-Sheng; Dong, Xin; Guan, Yun-Feng; Qi, Qi; Hu, Wen-Jun; Hong, Chen; Zhang, Chuan; Miao, Chao-Yu

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 299-309. DOI: 10.2174/1389201023666220518113219
3、Factors and Mechanisms Affecting the Secretion of Recombinant Protein in CHO Cells
Author: Yang, Yong-Xiao; Li, Qin; Li, Wei-Dong; Wang, Tian-Yun; Feng, Hui-Gen

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 391-400. DOI: 10.2174/1389201023666220603121316
4、Research Progress in Elucidating the Mechanisms Underlying Resveratrol Action on Lung Cancer
Author: Xin, Rui; Shen, Biao; Huang, Zhong-Yan; Liu, Ji-Bin; Li, Sha; Jiang, Geng-Xi; Zhang, Jie; Cao, Ya-Hong; Zou, Da-Zhi; Li, Wen; Li, Chun-Guang; Ma, Yu-Shui; Fu, Da

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 427-437. DOI: 10.2174/1389201023666220818085945
5、Production of Recombinant Human Hybrid Ferritin with Heavy Chain and Light Chain in Escherichia coli and its Characterization
Author: Song, Xiaotong; Zheng, Yongxiang; Liu, Yongdong; Meng, Huan; Yu, Rong; Zhang, Chun

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 341-349. DOI: 10.2174/1389201023666220517225048
6、LTBP1 Gene Expression in the Cerebral Cortex and its Neuroprotective Mechanism in Mice with Postischemic Stroke Epilepsy
Author: Liu, Bo; Wang, Yan; He, Dongruo; Han, Guochao; Wang, Hao; Lin, Yuan; Zhang, Tianyu; Yi, Chao; Li, Hui

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 317-329. DOI: 10.2174/1389201023666220608091511
7、N-acetyl Cysteine Inhibits Cell Proliferation and Differentiation of LPS-Induced MC3T3-E1 Cells Via Regulating Inflammatory Cytokines
Author: Li, Wangyang; Zhang, Hui; Chen, Junchi; Tan, Yujie; Li, Ailing; Guo, Ling

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 3, pp. 450-459. DOI: 10.2174/1389201023666220520102001
8、Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma Cells by Promoting Apoptosis
Author: Li, Dan; Luo, Dongdong; Hu, Su; Zhao, Hailin; Peng, Biao

Journal: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. 2023; Vol. 24, Issue 2, pp. 310-316. DOI: 10.2174/1389201023666220513100129